Literature DB >> 29691287

Systematic Modeling and Design Evaluation of Unperturbed Tumor Dynamics in Xenografts.

Zinnia P Parra-Guillen1, Victor Mangas-Sanjuan1, Maria Garcia-Cremades1, Iñaki F Troconiz1, Gary Mo1, Celine Pitou1, Philip W Iversen1, Johan E Wallin2.   

Abstract

Xenograft mice are largely used to evaluate the efficacy of oncological drugs during preclinical phases of drug discovery and development. Mathematical models provide a useful tool to quantitatively characterize tumor growth dynamics and also optimize upcoming experiments. To the best of our knowledge, this is the first report where unperturbed growth of a large set of tumor cell lines (n = 28) has been systematically analyzed using a previously proposed model of nonlinear mixed effects (NLME). Exponential growth was identified as the governing mechanism in the majority of the cell lines, with constant rate values ranging from 0.0204 to 0.203 day-1 No common patterns could be observed across tumor types, highlighting the importance of combining information from different cell lines when evaluating drug activity. Overall, typical model parameters were precisely estimated using designs in which tumor size measurements were taken every 2 days. Moreover, reducing the number of measurements to twice per week, or even once per week for cell lines with low growth rates, showed little impact on parameter precision. However, a sample size of at least 50 mice is needed to accurately characterize parameter variability (i.e., relative S.E. values below 50%). This work illustrates the feasibility of systematically applying NLME models to characterize tumor growth in drug discovery and development, and constitutes a valuable source of data to optimize experimental designs by providing an a priori sampling window and minimizing the number of samples required.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29691287     DOI: 10.1124/jpet.118.248286

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  3 in total

1.  Translational Framework Predicting Tumour Response in Gemcitabine-Treated Patients with Advanced Pancreatic and Ovarian Cancer from Xenograft Studies.

Authors:  Maria Garcia-Cremades; Celine Pitou; Philip W Iversen; Iñaki F Troconiz
Journal:  AAPS J       Date:  2019-01-31       Impact factor: 4.009

Review 2.  Beyond Deterministic Models in Drug Discovery and Development.

Authors:  Itziar Irurzun-Arana; Christopher Rackauckas; Thomas O McDonald; Iñaki F Trocóniz
Journal:  Trends Pharmacol Sci       Date:  2020-10-05       Impact factor: 14.819

3.  Population modeling of tumor growth curves and the reduced Gompertz model improve prediction of the age of experimental tumors.

Authors:  Cristina Vaghi; Anne Rodallec; Raphaëlle Fanciullino; Joseph Ciccolini; Jonathan P Mochel; Michalis Mastri; Clair Poignard; John M L Ebos; Sébastien Benzekry
Journal:  PLoS Comput Biol       Date:  2020-02-25       Impact factor: 4.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.